Skip to main content


Wednesday, October 23, 2013
Incubating a new business at Cornell

ITHACA At a time when politicians, practitioners and insurance companies are scrounging around the health care system for ways to save money, a budding Ithaca company is gearing up to radically reduce the cost of many medications.

Scientists at biotech startup Glycobia have invented a method to manufacture glycoprotein drugs, which are used to treat a wide array of diseases, ranging from cancer to multiple sclerosis to rare genetic diseases. Through genetic engineering, the researchers are inducing Escherichia coli (E.coli) to produce the drugs, taking advantage of the bacterium's ability to do so quickly and cheaply...